The DOI matches its Crossref record, with a small difference in title or year; 54 of the 56 references it cites were found in a registry or an index.
Antidepressant Drug Effects and Depression Severity: A Patient-Level Meta-analysis
Open accessAbstract
CONTEXT: Antidepressant medications represent the best established treatment for major depressive disorder, but there is little evidence that they have a specific pharmacological effect relative to pill placebo for patients with less severe depression. OBJECTIVE: To estimate the relative benefit of medication vs placebo across a wide range of initial symptom severity in patients diagnosed with depression. DATA SOURCES: PubMed, PsycINFO, and the Cochrane Library databases were searched from January 1980 through March 2009, along with references from meta-analyses and reviews. STUDY SELECTION: Randomized placebo-controlled trials of antidepressants approved by the Food and Drug Administration in the treatment of major or minor depressive disorder were selected. Studies were included if their authors provided the requisite original data, they comprised adult outpatients, they included a medication vs placebo comparison for at least 6 weeks, they did not exclude patients on the basis of a placebo washout period, and they used the Hamilton Depression Rating Scale (HDRS). Data from 6 studies (718 patients) were included. DATA EXTRACTION: Individual patient-level data were obtained from study authors. RESULTS: Medication vs placebo differences varied substantially as a function of baseline severity. Among patients with HDRS scores below 23, Cohen d effect sizes for the difference between medication and placebo were estimated to be less than 0.20 (a standard definition of a small effect). Estimates of the magnitude of the superiority of medication over placebo increased with increases in baseline depression severity and crossed the threshold defined by the National Institute for Clinical Excellence for a clinically significant difference at a baseline HDRS score of 25. CONCLUSIONS: The magnitude of benefit of antidepressant medication compared with placebo increases with severity of depression symptoms and may be minimal or nonexistent, on average, in patients with mild or moderate symptoms. For patients with very severe depression, the benefit of medications over placebo is substantial.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“antidepressants have been demonstrated efficient in treating MDD”
From SSRI Treatment Response Prediction in Depression Based on Brain Activation by Emotional Stimuli (2020) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Fournier and colleagues meta-analysed trials of selective serotonin reuptake inhibitors and estimated the effect size.45 For mild to severe depression the effect estimates ranged from -0.17 to -0.11; this is lower than the effect size for smoking cessation.”
From Change in mental health after smoking cessation: systematic review and meta-analysis (2014) · cites this paper as [45]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For SSRIs, researchers have argued that a substantial portion of the perceived therapeutic benefit in double-blind randomized clinical trials (RCTs) may stem from placebo responses rather than the drug itself (Sugarman et al., 2014; Fournier et al., 2010; Kirsch, 2014; Moncrieff and Kirsch, 2015).”
From Revisiting the SSRI vs. placebo debate in the treatment of social anxiety disorder: the role of expectancy effects, neural responsivity, and monoamine transporters (2025) · cites this paper as Fournier et al., 2010
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The introduction and widespread use of selective serotonine uptake inhibitors (SSRI) [22, 23] and psychological therapy including cognitive behavioral therapy (CBT) [24, 25] meant that well tolerated and effective treatments for depression and anxiety disorders became available in primary care, widening the group of individuals eligible for treatment.”
From Trends in psychiatric diagnoses, medications and psychological therapies in a large Swedish region: A population-based study (2020) · cites this paper as [23]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“there are differences in individual response”
From SSRI Treatment Response Prediction in Depression Based on Brain Activation by Emotional Stimuli (2020) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“In addition, the effect sizes are generally higher than those obtained for pharmacological treatment of mild-to-moderate depression [34]”
From One-Day Acceptance and Commitment Therapy Compared to Support for Depressed Migraine Patients: a Randomized Clinical Trial. (2020) · cites this paper as [34]
In the citing paper
“Two individual participant data meta-analysis (26, 27) indicated that patients with lower baseline severity would achieve smaller improvement compared to placebo.”
In the citing paper
“Individual-level meta-analyses have found a direct relationship between the magnitude of depressive symptoms and the effectiveness of antidepressants.8–10”
In the citing paper
“Thus, the benefits of antidepressants in non-severe depression have been argued to be minimal.8 11”
In the citing paper
“One small individual patient data meta-analysis found support for increasing benefit with increasing severity of depression,20 but three larger individual patient data meta-analyses did not find any such effect of antidepressants compared with placebo on depression severity .44–46”
From Should antidepressants be used for major depressive disorder? (2020) · cites this paper as [20]
In the citing paper
“For example, meta-analysis has demonstrated that antidepressants, though widely prescribed as a treatment for MDD, may be no more effective than placebo for mild to moderate levels of symptom severity; clinically significant benefits are only observed at “very severe” levels of impairment (18).”
From Depression in diabetes: have we been missing something important? (2011) · cites this paper as [18]
In the citing paper
“For example, meta-analysis has demonstrated that antidepressants, though widely prescribed as a treatment for MDD, may be no more effective than placebo for mild to moderate levels of symptom severity; clinically significant benefits are only observed at “very severe” levels of impairment (18).”
From Depression in diabetes: have we been missing something important? (2011) · cites this paper as [18]
In the citing paper
“Although antidepressants are unlikely to be effective in most presentations of distress (18), physical activity, psychotherapeutic approaches, and discussions with diabetes team members can be effective.”
From Depression in diabetes: have we been missing something important? (2011) · cites this paper as [18]
In the citing paper
“The strength of the pooled standardised mean difference in change was clinically important - the association between smoking cessation and change in depression and anxiety was equal to or larger than the estimate from trials of antidepressants versus placebo.”
From An application of the stress-diathesis model: A review about the association between smoking tobacco, smoking cessation, and mental health (2023) · cites this paper as Fournier et al., 2010
In the citing paper
“A meta-analysis of individual-level data from randomised controlled trials (RCTs) of antidepressants for”
From An application of the stress-diathesis model: A review about the association between smoking tobacco, smoking cessation, and mental health (2023) · cites this paper as Fournier et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences
Muller, K. E., & Cohen, J. (1989) · Technometrics · doi:10.2307/1270020 · Cited by 99,603
Statistical power analysis for the behavioral sciences
Cohen, J. (1990) · Computers Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,417
Statistical Power Analysis for the Behavioral Sciences (2nd ed.).
Lachenbruch, P. A., & Cohen, J. (1989) · Journal of the American Statistical Association · doi:10.2307/2290095 · Cited by 37,421
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050045 · Cited by 2,442
Selective publication of antidepressant trials and its influence on apparent efficacy
Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa065779 · Cited by 2,435
Elkin, I. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110013002 · Cited by 2,300
Dimidjian, S., Hollon, S. D., Dobson, K. S., Schmaling, K. B., Kohlenberg, R. J., Addis, M. E., Gallop, R., McGlinchey, J. B., Markley, D. K., Gollan, J. K., et al. (2006) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.74.4.658 · Cited by 1,607
Self-citationOstwald, P. F. (1960) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.1960.14.4.817 · Cited by 1,422
The Hamilton Depression Rating Scale: Has the Gold Standard Become a Lead Weight?
Bagby, R. M., Ryder, A. G., Schuller, D. R., & Marshall, M. B. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.12.2163 · Cited by 1,148
Research works printed but not linked: 1
- [3]Depression Guideline Panel Depression in primary care: Vol. 2. Treatment of major depression Clinical Practice Guideline No. 5. AHCPR Publication No. 93-0551 Rockville, MD U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research 1993
Cited by
Sorted by citations
Items 901–1,000 of 1,006
Peripheral Biomarkers in Animal Models of Major Depressive Disorder
Carboni, L. (2013) · Disease Markers · doi:10.1155/2013/284543 · Cited by 18
Accounting for baseline differences in meta-analysis
Chaimani, A. (2014) · Evidence-Based Mental Health · doi:10.1136/eb-2014-102035 · Cited by 17
Acquaviva, É., Peyre, H., & Falissard, B. (2011) · Neuropsychiatrie de l Enfance et de l Adolescence · doi:10.1016/j.neurenf.2011.10.009 · Cited by 18
Hirschtritt, M. E., Pagano, M. E., Christian, K. M., McNamara, N., Stansbrey, R. J., Lingler, J., Faber, J. E., Demeter, C., Bedoya, D., & Findling, R. L. (2011) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2011.09.010 · Cited by 17
Der Placeboeffekt in der antidepressiven Behandlung
Kirsch, I. (2016) · Verhaltenstherapie · doi:10.1159/000443542 · Cited by 18
A review of ketamine’s role in ECT and non-ECT settings
Jankauskas, V., Necyk, C., Chue, J., & Chue, P. S. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s157233 · Cited by 19
Brain-derived neurotrophic factor signaling mitigates the impact of acute social stress
Rosenhauer, A. M., Beach, L. Q., Jeffress, E. C., Thompson, B. M., McCann, K. E., Partrick, K. A., Diaz, B., Norvelle, A., Choi, D. C., & Huhman, K. L. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.12.016 · Cited by 19
Children’s age at parental divorce and depression in early and mid-adulthood
Kravdal, Ø., & Grundy, E. M. D. (2019) · Population Studies · doi:10.1080/00324728.2018.1549747 · Cited by 17
Magnetic seizure therapy for treatment-resistant depression
Jiang, J., Zhang, C., Li, C., Chen, Z., Cao, X., Wang, H., Li, W., & Wang, J. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013528.pub2 · Cited by 19
Masoudi, M., Ansari, S., Kashani, L., Tavolinejad, H., Rashidi, B. H., Esalatmanesh, S., Ghazizadeh‐Hashemi, M., Noorbala, A. A., & Akhondzadeh, S. (2021) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000367 · Cited by 17
α2 Adrenergic Receptor Trafficking as a Therapeutic Target in Antidepressant Drug Action
Cottingham, C., Ferryman, C. J., & Wang, Q. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.03.007 · Cited by 17
Burning issues in the meta-analysis of pharmaceutical trials for depression
Fountoulakis, K. Ν., Samara, M. T., & Siamouli, M. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113504014 · Cited by 17
Pizzi, L. T., Jutkowitz, E., Frick, K. D., Suh, D., Prioli, K. M., & Gitlin, L. N. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13146 · Cited by 17
Iatrogenia y prevención cuaternaria en salud mental
Lobo, A. O., & Rojo, V. (2011) · Revista Española de Salud Pública · doi:10.1590/s1135-57272011000600002 · Cited by 19
Suggestibility as a predictor of response to antidepressants: A preliminary prospective trial
Nitzan, U., Chalamish, Y., Krieger, I., Erez, H. B., Braw, Y., & Lichtenberg, P. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.06.028 · Cited by 19
Initiation of Antidepressant Medication After Hip Fracture in Community-Dwelling Older Adults
Iaboni, A., Seitz, D. P., Fischer, H. D., Diong, C. C., Rochon, P. A., & Flint, A. J. (2014) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2014.10.002 · Cited by 17
First, Do No Harm: Referring Primary Care Patients with Depression to an Internet Support Group
Goodwin, B., Ford, D. E., Hsiung, R. C., Houston, T. K., Fogel, J., & Voorhees, B. W. V. (2017) · Telemedicine Journal and e-Health · doi:10.1089/tmj.2017.0004 · Cited by 17
An Economic Theory of Depression and its Impact on Health Behavior and Longevity
Strulik, H. (2018) · Journal of Economic Behavior & Organization · doi:10.1016/j.jebo.2018.11.022 · Cited by 19
Vicarious Experience Affects Patients' Treatment Preferences for Depression
Berkowitz, S. A., Bell, R. A., Kravitz, R. L., & Feldman, M. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031269 · Cited by 17
Panteleimon Ekkekakis, A. (2020) · Kinesiology Review · doi:10.1123/kr.2020-0036 · Cited by 18
Kuroda, N., Burkey, M. D., & Wissow, L. S. (2021) · Journal of General Internal Medicine · doi:10.1007/s11606-020-06449-y · Cited by 16
Bargaining models of depression and evolution of cooperation
Rosenström, T. H. (2013) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2013.04.012 · Cited by 16
Schacht, A., Gorwood, P. A. P. M., Boyce, P. M., Schaffer, A., & Picard, H. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.02.001 · Cited by 16
Furukawa, T. A., Schramm, E., Weitz, E. S., Salanti, G., Efthimiou, O., Michalak, J., Watanabe, N., Cipriani, A., Keller, M. B., Kocsis, J. H., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011769 · Cited by 16
Szopa, A., Bogatko, K., Serefko, A., Wyska, E., Wośko, S., Świąder, K., Doboszewska, U., Właź, A., Wróbel, A., Właź, P., et al. (2019) · Pharmacological Reports · doi:10.1016/j.pharep.2019.03.007 · Cited by 16
Examining raphe-amygdala structural connectivity as a biological predictor of SSRI response
Pillai, R. L. I., Huang, C., LaBella, A., Zhang, M., Yang, J., Trivedi, M. H., Weissman, M. M., McGrath, P. J., D, M. F. M., Kurian, B. T., et al. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.05.055 · Cited by 16
Maggo, S. D. S., Kennedy, M. A., Barczyk, Z. A., Miller, A. L., Rucklidge, J. J., Mulder, R., & Foulds, J. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.01199 · Cited by 20
Jiang, N., Huang, H. M., Wang, H., Lv, J., Zeng, G., Wang, Q., Bao, Y., Chen, Y., & Liu, X. (2021) · Phytotherapy Research · doi:10.1002/ptr.7017 · Cited by 16
Treating Postpartum Depression: What Do We Know about Brexanolone?
Ali, M., Aamir, A., Diwan, M. N., Awan, H. A., Ullah, I., Irfan, M., & Berardis, D. D. (2021) · Diseases · doi:10.3390/diseases9030052 · Cited by 17
Clinical Pharmacology and Therapeuticsof Antidepressants
Ciraulo, D. A., Shader, R. I., & Greenblatt, D. J. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-435-7_2 · Cited by 17
Clinical characteristics of patients with diagnostic uncertainty of major depressive disorder
Mogi, T., Toda, H., & Yoshino, A. (2017) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2017.10.001 · Cited by 17
Capillary electrophoresis for the analysis of antidepressant drugs: A review
Keyon, A. S. A., Miskam, M., Ishak, N. S., Mahat, N. A., Huri, M. A. M., Wahab, R. A., Chandren, S., Razak, F. I. A., Ng, N., & Ali, T. G. (2019) · Journal of Separation Science · doi:10.1002/jssc.201800859 · Cited by 16
Foster, S., Mohler‐Kuo, M., Tay, L. S., Hothorn, T., & Seibold, H. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.02.021 · Cited by 16
Utilizing placebos to leverage effects of cognitive-behavioral therapy in patients with depression
Jurinec, N., & Schienle, A. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.08.087 · Cited by 20
Improving study design for antidepressant effectiveness assessment
Naudet, F., Millet, B., Reymann, J. M., & Falissard, B. (2013) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1391 · Cited by 15
Antidepressants and advertising: psychopharmaceuticals in crisis.
Greenslit, N., & Kaptchuk, T. J. (2012) · Europe PMC (PubMed Central) · Cited by 16
Depression in patients with heart disease: the case for more trials
Liu, S. S., & Ziegelstein, R. C. (2010) · Future Cardiology · doi:10.2217/fca.10.18 · Cited by 15
Ghaemi, S. N., Vöhringer, P. A., & Whitham, E. A. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12059 · Cited by 15
Trends in Outpatient Treatment for Depression in Survivors of Stroke in the United States, 2004–2017
Dong, L., Mezuk, B., Williams, L. S., & Lisabeth, L. D. (2022) · Neurology · doi:10.1212/wnl.0000000000200286 · Cited by 17
Coping strategies for antidepressant side effects: An Internet survey
Kikuchi, T., Suzuki, T., Uchida, H., Watanabe, K., & Mimura, M. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.04.039 · Cited by 16
Newer antidepressants for the treatment of depression in adults
Hatcher, S., & Arroll, B. (2012) · BMJ · doi:10.1136/bmj.d8300 · Cited by 15
Symptom Severity and the Generalizability of Antidepressant Efficacy Trials
Zimmerman, M. A., Clark, H., Multach, M. D., Walsh, E. K., Rosenstein, L. K., & Gazarian, D. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000466 · Cited by 15
Does the Use of Psychotropic Medication Adversely Affect the Outcomes of Hip Arthroscopy?
Youlo, S. T., Walczak, B. E., & Keene, J. S. (2018) · The American Journal of Sports Medicine · doi:10.1177/0363546518801881 · Cited by 15
Bø, R., Kraft, B., Jonassen, R., Harmer, C. J., Hilland, E., Stiles, T. C., Haaland, V. Ø., Aspesletten, M. E. B., Sletvold, H., & Landrø, N. I. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.04.027 · Cited by 15
Exercise as antidepressant treatment: Time for the transition from trials to clinic?
Ekkekakis, P., & Murri, M. B. (2017) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2017.11.004 · Cited by 20
Public Mental Health: Global Perspectives
Knifton, L., & Quinn, N. (2013) · Cited by 15
Telephone‐based care management for older adults initiated on psychotropic medication
Maust, D. T., Mavandadi, S., Benson, A., Streim, J. E., DiFilippo, S. D., Snedden, T. M., Weber, A. L., & Oslin, D. W. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3839 · Cited by 15
Assessment of cognitive safety in clinical drug development
Roiser, J. P., Nathan, P. J., Mander, A., Adusei, G. O., Zavitz, K. H., & Blackwell, A. D. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.11.003 · Cited by 15
Treating Depression: What Patients Want; Findings From a Randomized Controlled Trial in Primary Care
Magnani, M., Sasdelli, A., Bellino, S., Bellomo, A., Carpiniello, B., Politi, P., Menchetti, M., & Berardi, D. (2016) · Psychosomatics · doi:10.1016/j.psym.2016.05.004 · Cited by 17
Fountoulakis, K. Ν., McIntyre, R. S., & Carvalho, A. F. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150630174343 · Cited by 17
Effect of vitamin D replacement on depression in multiple sclerosis patients
Kotb, M. A., Kamal, A. M., Aldossary, N. M., & Bedewi, M. A. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.01.029 · Cited by 15
Cao, B., Xu, L., Chen, Y., Wang, D., Lee, Y. L., Rosenblat, J. D., Gao, X., Zhan, S., Sun, F., & McIntyre, R. S. (2021) · CNS Spectrums · doi:10.1017/s1092852921000171 · Cited by 15
Implementing Adaptive Health Practice: A Complexity-Based Philosophy of Health Care
Thygeson, N. M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4998-0_38 · Cited by 16
Starting from something: augmenting exposure therapy and methods of inquiry
Tuerk, P. W. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14070880 · Cited by 15
Configuring Health Care for Systematic Behavioral Screening and Intervention
Brown, R. L. (2011) · Population Health Management · doi:10.1089/pop.2010.0075 · Cited by 14
Recent Progress in Biosensors for Depression Monitoring—Advancing Personalized Treatment
Yin, J., Jia, X., Li, H., Zhao, B., Yang, Y. A., & Ren, T. (2024) · Biosensors · doi:10.3390/bios14090422 · Cited by 14
Deng, Z., Wang, W., Nie, Z., Ma, S., Zhou, E., Xie, X., Gong, Q., Yao, L., Bu, L., Kang, L., et al. (2025) · NeuroImage Clinical · doi:10.1016/j.nicl.2025.103769 · Cited by 15
The Social Work Practice Research Conundrum
Wodarski, J. S. (2011) · Journal of Human Behavior in the Social Environment · doi:10.1080/10911359.2011.580249 · Cited by 14
Fu, Y., Song, Y., Li, Y., Sánchez-Vidaña, D. I., Zhang, J., Lau, W. K., Tan, D. G. H., Ngai, S. P. C., & Lau, B. W.-M. (2024) · Scientific Reports · doi:10.1038/s41598-024-71213-9 · Cited by 25
Ohtani, Y., Tani, H., Nomoto‐Takahashi, K., Yatomi, T., Yonezawa, K., Tomiyama, S., Nagai, N., Kusudo, K., Honda, S., Moriyama, S., et al. (2024) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13734 · Cited by 14
Parker, G. B., & McCraw, S. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12427 · Cited by 14
The role of obsessive beliefs in patients with major depressive disorder
Bahçeci, B., Bağcıoğlu, E., Çelik, F. H., Polat, S., Köroğlu, A., Kandemir, G., & Hocaoğlu, Ç. (2013) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2013.859707 · Cited by 14
Is placebo useful in the treatment of major depression in clinical practice?
Marchesi, C., Panfilis, C. D., Tonna, M., & Ossola, P. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s44519 · Cited by 13
A Pill for the Ill? Depression, Medicalization and Public Health.
Vilhelmsson, A. (2014) · Socialmedicinsk tidskrift · doi:10.62607/smt.v91i1.43076 · Cited by 14
Adler, U. C., Krüger, S., Teut, M., Lüdtke, R., Bartsch, I., Schützler, L., Melcher, F., Willich, S. N., Linde, K., & Witt, C. M. (2011) · Trials · doi:10.1186/1745-6215-12-43 · Cited by 14
Preventing Depression in Later Life: State of the Art and Science Circa 2011
Hindi, F., Dew, M. A., Albert, S. M., Lotrich, F. E., & Reynolds, C. F. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2010.11.008 · Cited by 14
Rhodiola rosea (SHR-5), Part 2
Ross, S. M. (2014) · Holistic Nursing Practice · doi:10.1097/hnp.0000000000000030 · Cited by 13
Pies, R. W. (2015) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000455 · Cited by 14
Magnée, T., Beurs, D. P. D., Schellevis, F., & Verhaak, P. F. M. (2018) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813432.2018.1426145 · Cited by 13
Psilocybin for depression: Considerations for clinical trial design
O’Donnell, K. C., Mennenga, S. E., & Bogenschutz, M. P. (2019) · Journal of Psychedelic Studies · doi:10.1556/2054.2019.026 · Cited by 18
Mental health outcomes of balneotherapy: a systematic review
Clark-Kennedy, J., Kennedy, G. A., Cohen, M. M., & Conduit, R. (2021) · International Journal of Spa and Wellness · doi:10.1080/24721735.2021.1913368 · Cited by 14
Sforzini, L. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100331 · Cited by 14
Psychological Burden of Diabetes and What It Means to People with Diabetes
Barnard, K. D., Lloyd, C. E., & Holt, R. I. G. (2011) · Springer eBooks · doi:10.1007/978-0-85729-573-6_1 · Cited by 14
Tricyclic antidepressants exhibit variable pharmacological profiles at the α2A adrenergic receptor
Cottingham, C., Percival, S. M., Birky, T. L., & Wang, Q. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.08.024 · Cited by 14
Improving Recovery After Stroke
Adams, H. P., & Robinson, R. G. (2012) · Stroke · doi:10.1161/strokeaha.111.640524 · Cited by 14
Why medication in involuntary treatment may be less effective: The placebo/nocebo effect
Meynen, G., & Swaab, D. F. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.08.029 · Cited by 14
Conflicts of interest in psychiatry: Strategies to cultivate literacy in daily practice
Shimazawa, R., & Ikeda, M. (2014) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12201 · Cited by 14
Thase, M. E., Asami, Y., Wajsbrot, D., Dorries, K. M., Boucher, M., & Pappadopulos, E. A. (2016) · Current Medical Research and Opinion · doi:10.1080/03007995.2016.1255185 · Cited by 16
Massoudi, B., Blanker, M. H., van Valen, E., Wouters, H., Bockting, C., & Burger, H. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1376-1 · Cited by 15
Xiong, N., Liu, Q., Lv, X., Leonhart, R., Tian, H., Wei, J., Zhang, K., Zhu, G., Chen, Q., Wang, G., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.05.065 · Cited by 14
Measures of depression and incident type 2 diabetes in a community sample
Graham, E. A., Deschênes, S. S., Rosella, L. C., & Schmitz, N. (2020) · Annals of Epidemiology · doi:10.1016/j.annepidem.2020.11.010 · Cited by 15
Cebrino, J., & de la Cruz, S. P. (2020) · Nutrients · doi:10.3390/nu13010106 · Cited by 13
Hunter, A. M., Cook, I. A., Tartter, M. A., Sharma, S. K., Disse, G. D., & Leuchter, A. F. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4047-2 · Cited by 14
An electronic health record driven algorithm to identify incident antidepressant medication users
Bobo, W. V., Pathak, J., Kremers, H. M., Yawn, B. P., Brue, S. M., Stoppel, C. J., Croarkin, P. E., Sauver, J. L. S., Frye, M. A., & Rocca, W. A. (2014) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2014-002699 · Cited by 13
Ang, Y.-S., Bruder, G. E., Keilp, J. G., Rutherford, A., Alschuler, D. M., Pechtel, P., Webb, C. A., Carmody, T., Fava, M., Cusin, C., et al. (2022) · Psychological Medicine · doi:10.1017/s0033291720004286 · Cited by 12
Sharpley, C. F., & Bitsika, V. (2011) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2010.527008 · Cited by 14
Shallcross, A. J., Duberstein, Z. T., Sperber, S. H., Visvanathan, P. D., Lutfeali, S., Lu, N. Y., Carmody, J., & Spruill, T. M. (2021) · Cognitive and Behavioral Practice · doi:10.1016/j.cbpra.2020.12.004 · Cited by 13
Johansson, R. (2013) · Linköping studies in behavioural science · doi:10.3384/diss.diva-100385 · Cited by 13
Rost, N., Dwyer, D., Gaffron, S., Rechberger, S., Maier, D., Binder, E. B., & Brückl, T. M. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.02.007 · Cited by 15
Therapeutic role of psilocybin and 3,4-methylenedioxymethamphetamine in trauma: A literature review
Fonseka, L. N., & Woo, B. K. P. (2023) · World Journal of Psychiatry · doi:10.5498/wjp.v13.i5.182 · Cited by 15
Mental health in the virtual world: Challenges and opportunities in the metaverse era
del Hoyo, Y. L., Elices, M., & García‐Campayo, J. (2024) · World Journal of Clinical Cases · doi:10.12998/wjcc.v12.i17.2939 · Cited by 14
Guidetti, C., Feeney, A., Hock, R. S., Iovieno, N., Ortiz, J. M. H., D, M. F. M., & Papakostas, G. I. (2024) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000554 · Cited by 12
What we got wrong about depression and its treatment
Hollon, S. D. (2024) · Behaviour Research and Therapy · doi:10.1016/j.brat.2024.104599 · Cited by 13
Self-citationEffect of DLPFC rTMS on anhedonia and alpha asymmetry in depressed patients
Kazemi, R., Rostami, R., Hadipour, A., Zandbagleh, A., Khomami, S., Kiaee, N., Coetzee, J. P., Philips, A., & Adamson, M. M. (2025) · Scientific Reports · doi:10.1038/s41598-024-85057-w · Cited by 11
Ozpolat, M. C., Okcay, Y., Ulusoy, K. G., & Yıldız, O. (2025) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-025-03818-6 · Cited by 15
Reflections on Neuroenhancement
Glannon, W. (2014) · Springer eBooks · doi:10.1007/978-94-007-4707-4_93 · Cited by 13
Robiner, W. N., Tumlin, T. R., & Tompkins, T. L. (2013) · Clinical Psychology Science and Practice · doi:10.1111/cpsp.12054 · Cited by 16
Depressed Parents' Treatment Needs and Children's Problems in an Urban Family Medicine Practice
Vidair, H. B., Boccia, A. S., Johnson, J. G., Verdeli, H., WICKRAMARATNE, P. J., Klink, K. A., Softness, A. M., Dominguez-Rafer, C., Younge, R. G., & Weissman, M. M. (2011) · Psychiatric Services · doi:10.1176/ps.62.3.pss6203_0317 · Cited by 14
Puyat, J. H., Kazanjian, A., Wong, H., & Goldner, E. M. (2016) · Medical Care · doi:10.1097/mlr.0000000000000639 · Cited by 13
Correa, K. A., Li, L. Y., Nelson, B. D., & Shankman, S. A. (2022) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2022.01.016 · Cited by 13
Metadata
- Authors
- Fournier, J. C., DeRubeis, R. J., Hollon, S. D., Dimidjian, S., Amsterdam, J. D., Shelton, R. C., & Fawcett, J.
- Affiliations
- University of Pennsylvania (US)
- University of New Mexico (US)
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2010-01-06
- Volume
- 303
- Issue
- 1
- Pages
- 47
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- PMC
- PMC3712503
- OpenAlex
- W2004762037
- Cited by
- 2,009
- References
- 56
- Citations by year
- 2026: 54 · 2025: 72 · 2024: 89 · 2023: 70 · 2022: 81 · 2021: 134 · 2020: 81 · 2019: 111 · 2018: 143 · 2017: 128 · 2016: 112 · 2015: 149 · 2014: 154 · 2013: 170 · 2012: 172
- FWCI
- 144.95
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- GlaxoSmithKline
- Sanofi
- National Alliance for Research on Schizophrenia and Depression
- Universiteit Maastricht
- National Institute of Mental Health (K24MH001741, R10 MH50129, R01MH060998, K02MH001697, R10MH055875, R10MH055877)
- Janssen Pharmaceuticals
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- antidepressants, major depressive disorder, depression severity, placebo response, Hamilton Depression Rating Scale, treatment effect heterogeneity, mild depression, antidepressant efficacy
- MeSH terms
- Adult, Antidepressive Agents, Depression, Major Depressive Disorder, Humans, Placebo Effect, Randomized Controlled Trials as Topic, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
